Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 5,190 | 4,848 | 4,475 | 4,258 | 4,186 |
| Cost of Goods | 1,194 | 1,033 | 1,044 | 880 | 1,069 |
| Gross Profit | 3,996 | 3,815 | 3,431 | 3,378 | 3,118 |
| Operating Expenses | 23,693 | 31,104 | 24,398 | 20,573 | 21,034 |
| Operating Income | -19,503 | -27,256 | -20,923 | -16,315 | -17,848 |
| Other Income | 30 | 28 | 28 | 13 | 16 |
| Pre-tax Income | -19,473 | -27,228 | -20,894 | -16,303 | -17,832 |
| Net Income Continuous | -19,473 | -27,228 | -20,894 | -16,303 | -17,832 |
| Net Income | $-19,473 | $-27,228 | $-20,894 | $-16,303 | $-17,832 |
| EPS Basic Total Ops | -5.50 | -8.00 | -6.50 | -5.50 | -6.00 |
| EPS Basic Continuous Ops | -5.49 | -7.88 | -6.39 | -5.34 | -5.86 |
| EPS Diluted Total Ops | -5.50 | -8.00 | -6.50 | -5.50 | -6.00 |
| EPS Diluted Continuous Ops | -5.49 | -7.88 | -6.39 | -5.34 | -5.86 |
| EBITDA(a) | $-19,487 | $-27,241 | $-20,909 | $-16,303 | $-17,835 |